- Home
- PD vs HROW Comparison
PD vs HROW Comparison
Compare PD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PD
- HROW
- Stock Information
- Founded
- PD 2009
- HROW 1998
- Country
- PD United States
- HROW United States
- Employees
- PD N/A
- HROW N/A
- Industry
- PD Computer Software: Prepackaged Software
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- PD Technology
- HROW Health Care
- Exchange
- PD Nasdaq
- HROW Nasdaq
- Market Cap
- PD 1.8B
- HROW 1.9B
- IPO Year
- PD 2019
- HROW N/A
- Fundamental
- Price
- PD $18.70
- HROW $38.90
- Analyst Decision
- PD Buy
- HROW Strong Buy
- Analyst Count
- PD 11
- HROW 4
- Target Price
- PD $21.82
- HROW $55.00
- AVG Volume (30 Days)
- PD 687.2K
- HROW 696.6K
- Earning Date
- PD 11-26-2024
- HROW 11-13-2024
- Dividend Yield
- PD N/A
- HROW N/A
- EPS Growth
- PD N/A
- HROW N/A
- EPS
- PD N/A
- HROW N/A
- Revenue
- PD $446,944,000.00
- HROW $169,138,000.00
- Revenue This Year
- PD $11.20
- HROW $58.50
- Revenue Next Year
- PD $10.97
- HROW $48.62
- P/E Ratio
- PD N/A
- HROW N/A
- Revenue Growth
- PD 10.08
- HROW 48.15
- 52 Week Low
- PD $16.46
- HROW $8.26
- 52 Week High
- PD $26.70
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- PD 51.08
- HROW 35.91
- Support Level
- PD $19.82
- HROW $38.96
- Resistance Level
- PD $20.56
- HROW $54.19
- Average True Range (ATR)
- PD 0.57
- HROW 2.83
- MACD
- PD 0.05
- HROW -0.78
- Stochastic Oscillator
- PD 38.57
- HROW 14.77
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its platform harnesses digital signals from virtually any software-enabled system or device and combines it with human response data to take the right actions in real-time. The product offerings of the company include PagerDuty Incident Management, DevOps, AIOPs, Process Automation, and Customer Service Operations.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.